Hidalgo OF - Search Results

1

Urokinase combination chemotherapy in small cell lung cancer. A phase II study.

Calvo FA, Hidalgo OF, Gonzalez F, Rebollo J, Martin Algarra S, Ortiz de Urbina D, Brugarolas A. Calvo FA, et al. Among authors: hidalgo of. Cancer. 1992 Dec 1;70(11):2624-30. doi: 10.1002/1097-0142(19921201)70:11<2624::aid-cncr2820701110>3.0.co;2-4. Cancer. 1992. PMID: 1330286 Clinical Trial.

2

Carboplatin (CBDCA), 5-fluorouracil (5-FU) and mitoxantrone (DHAD): an effective and well tolerated regimen for metastatic breast cancer.

Hidalgo OF, Gonzalez FG, Vieitez JM, Rebollo J, Tangco E, Herranz P. Hidalgo OF, et al. Ann Oncol. 1992 Jul;3(7):545-7. doi: 10.1093/oxfordjournals.annonc.a058257. Ann Oncol. 1992. PMID: 1498075 Free article. Clinical Trial.

3

Intra-arterial hepatic treatment with carboplatin (CBDCA) and 5-fluorouracil (5-FU) in metastases from colorectal carcinoma.

Hidalgo OF, Rebollo J, Vieitez JM, Bilbao I, Tangco E, Abuchaibe O, Pardo F. Hidalgo OF, et al. Am J Clin Oncol. 1993 Feb;16(1):30-3. doi: 10.1097/00000421-199302000-00008. Am J Clin Oncol. 1993. PMID: 8424401 Clinical Trial.

4

Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.

Hidalgo OF, Aramendía JM, Alonso G, Foncillas JG, Brugarolas A. Hidalgo OF, et al. Rev Med Univ Navarra. 1996 Jul-Sep;40(3):6-12. Rev Med Univ Navarra. 1996. PMID: 9499820 Clinical Trial.

5

[Intra-arterial chemotherapy, using the hepatic artery, in metastases of colorectal carcinoma].

Hidalgo OF, Gil AC, Campbell W, Hidalgo V, Santos M, Henríquez I, Martín S, Sureda M, Antón LM. Hidalgo OF, et al. Rev Med Univ Navarra. 1987 Jul-Sep;31(3):169-76. Rev Med Univ Navarra. 1987. PMID: 3333892 Review. Spanish.

6

Phase I trial of intermittent high-dose dacarbazine.

Buesa JM, Gracia M, Valle M, Estrada E, Hidalgo OF, Lacave AJ. Buesa JM, et al. Among authors: hidalgo of. Cancer Treat Rep. 1984 Mar;68(3):499-504. Cancer Treat Rep. 1984. PMID: 6704980

7

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Esteller M, et al. Among authors: hidalgo of. N Engl J Med. 2000 Nov 9;343(19):1350-4. doi: 10.1056/NEJM200011093431901. N Engl J Med. 2000. PMID: 11070098 Free article.

8

Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas.

Kudoh S, Wang Q, Hidalgo OF, Rayman P, Tubbs RR, Edinger MG, Kolenko V, Panuto J, Bukowski R, Finke JH. Kudoh S, et al. Among authors: hidalgo of. Cancer Immunol Immunother. 1995 Sep;41(3):175-84. doi: 10.1007/BF01521344. Cancer Immunol Immunother. 1995. PMID: 7553687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters